• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Bye, bye Negative Pressure Sales Team

anonymous

Guest
Medela cut the entire negative pressure sales force yesterday, save for four reps nationwide who will act in a hybrid role feeling out opportunities. Managers basically demoted to glorified remote rep roles, since they have no direct reports and are lucky to still be retained at all. Marketing team gone and cut to one person. Opportunities will be outsourced to MedPro. New EVP in the states really cleaned house. Good luck capturing market share from KCI with this model, Medela. Guess you are just a breast pump company after all. Which is fine, but maybe it’s time to make up your minds to be just that, instead of playing games with people’s livelihoods.
 




Medela cut the entire negative pressure sales force yesterday, save for four reps nationwide who will act in a hybrid role feeling out opportunities. Managers basically demoted to glorified remote rep roles, since they have no direct reports and are lucky to still be retained at all. Marketing team gone and cut to one person. Opportunities will be outsourced to MedPro. New EVP in the states really cleaned house. Good luck capturing market share from KCI with this model, Medela. Guess you are just a breast pump company after all. Which is fine, but maybe it’s time to make up your minds to be just that, instead of playing games with people’s livelihoods.